REALREAL INC/THE (REAL)

US88339P1012 - Common Stock

8.56  -0.95 (-9.99%)

After market: 8.9 +0.34 (+3.97%)

Fundamental Rating

2

REAL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 122 industry peers in the Specialty Retail industry. REAL may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, REAL is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

REAL had negative earnings in the past year.
REAL had a positive operating cash flow in the past year.
In the past 5 years REAL always reported negative net income.
In the past 5 years REAL always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -21.52%, REAL is not doing good in the industry: 82.64% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -21.52%
ROE N/A
ROIC N/A
ROA(3y)-33.63%
ROA(5y)-30.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 74.42%, REAL belongs to the best of the industry, outperforming 97.52% of the companies in the same industry.
In the last couple of years the Gross Margin of REAL has remained more or less at the same level.
REAL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.07%
GM growth 5Y1.35%

0

2. Health

2.1 Basic Checks

REAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, REAL has more shares outstanding
REAL has more shares outstanding than it did 5 years ago.
REAL has a worse debt/assets ratio than last year.

2.2 Solvency

REAL has an Altman-Z score of -2.39. This is a bad value and indicates that REAL is not financially healthy and even has some risk of bankruptcy.
REAL has a Altman-Z score of -2.39. This is amonst the worse of the industry: REAL underperforms 86.78% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.39
ROIC/WACCN/A
WACC8.78%

2.3 Liquidity

A Current Ratio of 0.94 indicates that REAL may have some problems paying its short term obligations.
REAL's Current ratio of 0.94 is on the low side compared to the rest of the industry. REAL is outperformed by 76.86% of its industry peers.
REAL has a Quick Ratio of 0.94. This is a bad value and indicates that REAL is not financially healthy enough and could expect problems in meeting its short term obligations.
REAL's Quick ratio of 0.85 is fine compared to the rest of the industry. REAL outperforms 71.07% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.85

5

3. Growth

3.1 Past

REAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.73%, which is quite impressive.
REAL shows a small growth in Revenue. In the last year, the Revenue has grown by 2.50%.
Measured over the past years, REAL shows a very strong growth in Revenue. The Revenue has been growing by 20.78% on average per year.
EPS 1Y (TTM)62.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)2.5%
Revenue growth 3Y22.35%
Revenue growth 5Y20.78%
Sales Q2Q%10.95%

3.2 Future

Based on estimates for the next years, REAL will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.40% on average per year.
The Revenue is expected to grow by 11.46% on average over the next years. This is quite good.
EPS Next Y57.58%
EPS Next 2Y30.33%
EPS Next 3Y23%
EPS Next 5Y18.4%
Revenue Next Year9.43%
Revenue Next 2Y8.71%
Revenue Next 3Y8.87%
Revenue Next 5Y11.46%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

REAL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for REAL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

REAL's earnings are expected to grow with 23.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.33%
EPS Next 3Y23%

0

5. Dividend

5.1 Amount

No dividends for REAL!.
Industry RankSector Rank
Dividend Yield N/A

REALREAL INC/THE

NASDAQ:REAL (12/18/2024, 7:39:55 PM)

After market: 8.9 +0.34 (+3.97%)

8.56

-0.95 (-9.99%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap938.95M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.52%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 74.42%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.43
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.94
Quick Ratio 0.85
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)62.73%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y57.58%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.5%
Revenue growth 3Y22.35%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y